BRANCACCIO, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 2.479
EU - Europa 1.785
NA - Nord America 1.377
SA - Sud America 555
AF - Africa 37
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.236
Nazione #
RU - Federazione Russa 1.310
US - Stati Uniti d'America 1.305
SG - Singapore 1.058
CN - Cina 521
BR - Brasile 441
VN - Vietnam 288
HK - Hong Kong 272
FR - Francia 164
KR - Corea 86
IT - Italia 84
JP - Giappone 69
GB - Regno Unito 56
AR - Argentina 48
DE - Germania 39
IN - India 37
CA - Canada 35
NL - Olanda 35
BD - Bangladesh 28
FI - Finlandia 23
EC - Ecuador 22
ID - Indonesia 20
MX - Messico 18
ZA - Sudafrica 16
CO - Colombia 14
IL - Israele 13
TR - Turchia 12
IQ - Iraq 10
SA - Arabia Saudita 10
LT - Lituania 8
PK - Pakistan 8
AT - Austria 7
AZ - Azerbaigian 7
BE - Belgio 7
CL - Cile 7
PL - Polonia 7
UA - Ucraina 7
UY - Uruguay 7
VE - Venezuela 7
PY - Paraguay 6
JO - Giordania 5
OM - Oman 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
EG - Egitto 4
ES - Italia 4
IE - Irlanda 4
PA - Panama 4
PH - Filippine 4
SE - Svezia 4
HN - Honduras 3
HR - Croazia 3
JM - Giamaica 3
KE - Kenya 3
KG - Kirghizistan 3
LB - Libano 3
PT - Portogallo 3
RO - Romania 3
SN - Senegal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GR - Grecia 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
CH - Svizzera 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
KW - Kuwait 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MR - Mauritania 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SV - El Salvador 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 6.236
Città #
Singapore 612
Santa Clara 609
Hong Kong 271
Hefei 202
San Jose 147
Lauterbourg 127
Ho Chi Minh City 91
Beijing 88
Seoul 86
Ashburn 72
Los Angeles 71
Hanoi 64
Tokyo 55
Dallas 50
Milan 33
São Paulo 31
New York 27
Rome 20
Frankfurt am Main 19
Rio de Janeiro 19
Buffalo 14
Haiphong 13
London 13
Toronto 13
Da Nang 12
Lappeenranta 12
Minamishinagawa 11
Orem 11
Bengaluru 10
Brasília 10
Bristol 10
Helsinki 10
Johannesburg 10
Belo Horizonte 9
Curitiba 9
Dhaka 9
Porto Alegre 9
Nuremberg 8
Brooklyn 7
Brussels 7
Campinas 7
Houston 7
Hải Dương 7
Lấp Vò 7
Quito 7
Riyadh 7
Baku 6
Buenos Aires 6
Chennai 6
Council Bluffs 6
Düsseldorf 6
Montevideo 6
Phoenix 6
Amman 5
Aracaju 5
Biên Hòa 5
Bình Dương Province 5
Can Tho 5
Guangzhou 5
Guayaquil 5
Lahore 5
Manchester 5
Marília 5
Montreal 5
Portsmouth 5
Baghdad 4
Bogotá 4
Carapicuíba 4
Denver 4
Dublin 4
Goiânia 4
Recife 4
Shanghai 4
Shenzhen 4
Tashkent 4
Vienna 4
Vitória da Conquista 4
Warsaw 4
Ankara 3
Anápolis 3
Athens 3
Blumenau 3
Boston 3
Bình Dương 3
Chicago 3
Cleveland 3
Concordia 3
Dakar 3
Didcot 3
Ha Long 3
Hortolândia 3
Jakarta 3
Joinville 3
Kingston 3
Kyiv 3
Macapá 3
Macaé 3
Maceió 3
Mumbai 3
Nairobi 3
Totale 3.163
Nome #
Analysis of the enzymatic activity of MMP-9 and MMP-2 on the recombinant domains of dystroglycan 725
Analysis at the molecular level of the interaction between ±-dystroglycan and ²-dystroglycan and assessment of its implication for skeletal muscle physiopathology 720
Verbascoside Elicits Its Beneficial Effects by Enhancing Mitochondrial Spare Respiratory Capacity and the Nrf2/HO-1 Mediated Antioxidant System in a Murine Skeletal Muscle Cell Line 89
Analysis of the GFP-labelled β-dystroglycan interactome in HEK-293 transfected cells reveals novel intracellular networks 89
O mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function 77
The missense mutation C667F in murine β-dystroglycan causes embryonic lethality, myopathy and blood-brain barrier destabilization 77
Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin 73
A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core portein in some, but not all, dystroglycanopathy patients 68
Structural model of domain 1 of the alfa-dystroglycan glycosylating enzyme LARGE 68
The molecular basis and biologic significance of the beta-dystroglycan-emerin interaction 66
Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1 61
The consequence of ATP synthase dimer angle on mitochondrial morphology studied by cryo-electron tomography 58
Identification of the beta-dystroglycan binding epitope within the C-terminal region of alpha-dystroglycan. 56
Molecular and structural basis of dystroglycanopathies 54
Agrin-Mediated Cardiac Regeneration: Some Open Questions 53
A primary dystroglycanopathy causing muscle-eye-brain disease with multicystic leukodystrophy: from cellular and biochemical analysis to a mouse model 53
Identification and Modeling of a GT-A Fold in the ?-Dystroglycan Glycosylating Enzyme LARGE1 51
Synchrotron Radiation as a tool for the investigation of the structural basis of primary dystroglycanopathies. 50
Determination of Agrin and Related Proteins Levels as a Function of Age in Human Hearts 50
A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. 50
High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of alpha-dystroglycan 49
Alpha-dystroglycan is a potential target of matrix metalloproteinase MMP-2 48
The α-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped viruses 48
The molecular basis of alpha-Dystroglycan hypoglycosylation: a crystallographic and SAXS study 48
Structural flexibility of human ?lpha-dystroglycan 46
Loss of dystroglycan drives cellular senescence via defective mitosis-mediated genomic instability 46
Perturbation of the alpha/beta-dystroglycan interaction: consequences for skeletal muscle stability 45
The effect of the pathological V72I, D109N and T190M missense mutations on the molecular structure of ?-dystroglycan 45
Structural flexibility of human alpha-dystroglycan 45
Analysis of alpha-Dystroglycan/LG Domain Binding Modes: Investigating Protein Motifs That Regulate the Affinity of Isolated LG Domains 45
Expression of multiple AQP4 pools in the plasma membrane and their association with the dystrophin complex 44
The enzymatic processing of ?-dystroglycan by MMP-2 is controlled by two anchoring sites distinct from the active site 44
The enzymatic processing of ?-dystroglycan by MMP-2 is controller by two anchoring sites distinct from the active site 44
Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy. 43
A molecular overview of the primary dystroglycanopathies 43
Live optical super-resolution microcospy applied to the characterization of maturation, localization and trafficking of defective dystroglycan mutants 42
optical nanoscopy applied to the characterization of maturation and localization of defective dystroglycan mutants 41
Intraring allostery controls the function and assembly of a hetero-oligomeric class II chaperonin. 41
Concerted mutation of Phe residues belonging to the beta-dystroglycan ectodomain strongly inhibits the interaction with alpha-dystroglycan in vitro 40
Insights from molecular dynamics simulations: Structural basis for the V567D mutation-induced instability of zebrafish alpha-dystroglycan and comparison with the murine model 40
Structural model of domain 1 of the alfa-dystroglycan glycosylating enzyme LARGE 40
Analisi strutturale e funzionale dei domini del distroglicano: ruolo per la stabilità del muscolo e aspetti fisiopatologici 40
MicroRNA from human peripheral blood leukocytes and cardiovascular diseases 39
?-Dystroglycan hypoglycosylation affects cell migration by influencing ?-dystroglycan membrane clustering and filopodia length: A musticale confocal microscopi analysis 38
Identification of the MMP-9 cleavage site on the recombinant b-dystroglycan ectodomain 38
Alpha-Dystroglycan is a potential target of matrix metalloproteinase MMP-2 37
The effect of an ionic detergent on the natively unfolded beta-dystroglycan ectodomain and on its interaction with alpha-dystroglycan 37
A second Ig-like domain identified in dystroglycan by molecular modelling and dynamics 37
Evaluating the role of the dystroglycan alpha/beta interface in human muscular dystrophies 35
Immunological dissection of the human dystroglycan complex 35
The Multiple Affinities of alpha-Dystroglycan 34
Modeling and molecular dynamics of alpha-dystroglycan's C-terminus reveals the presence of an Ig-like domain encompassing its beta-dystroglycan binding epitope 34
Evaluating the role of the dystroglycan alpha/beta interface in human muscular dystrophies 33
The structure of the T190M mutant of murine ?-dystroglycan at high resolution: insight into the molecular basis of a primary dystroglycanopathy 33
Internal (His)(6)-tagging delivers a fully functional hetero-oligomeric class II chaperonin in high yield 33
Mutagenesis at the alpha-beta interface impairs the cleavage of the dystroglycan precursor 33
±- and ²-dystroglycan: evaluation of processing and targeting through multiple fluorescent tagging 33
Enzymatic processing by MMP-2 and MMP-9 of wild-type and mutated mouse ss-dystroglycan 33
First molecular characterization and immunolocalization of keratoepithelin in adult human skeletal muscle 33
Identification of an Agrin Mutation that Causes Congenital Myasthenia and Affects Synapse Function 32
An adhesion molecule involved in muscular dystrophies: structural and functional analysis of dystroglycan domains 32
Il Distroglicano, un recettore coinvolto nelle distrofie muscolari: dalla biochimica cellulare ad un modello murino. 32
Dystroglycan is associated to the disulfide isomerase ERp57 32
Plasticity of secondary structure in the N-terminal region of beta-dystroglycan 31
A Gain-of-Glycosylation Mutation Associated with Myoclonus-Dystonia Syndrome Affects Trafficking and Processing of Mouse epsilon-Sarcoglycan in the Late Secretory Pathway 31
Analysis of dystroglycan in human patients affected by neuromuscular disorders.Analysis of dystroglycan in human patients affected by neuromuscular disorders 31
Structural characterization by NMR of the natively unfolded extracellular domain of beta-dystroglycan: toward the identification of the binding epitope for alpha-dystroglycan. 30
Localization of phospho-beta-dystroglycan (pY892) to an intracellular vesicular compartment in cultured cells and skeletal muscle fibers in vivo 30
Enzymatic Processing of beta-Dystroglycan Recombinant Ectodomain By MMP-9: Idendification of the Main Cleavage Site 30
Mutagenesis of the ±- and ²- dystroglycan interface 30
An immunological analysis of dystroglycan subunits: lessons learned from a small cohort of non-congenital dystrophic patients. 30
The molecular basis of ?-dystroglycan hypoglycosylation: a crystallographic and SAXS study 30
Structural insights into a protein folding machine 29
The evolution of the dystroglycan complex, a major mediator of muscle integrity. 29
Plasticity of secondary structure in the N-terminal region of beta-dystroglycan. 29
Evaluation of the effect of a floxed Neo cassette within the dystroglycan (Dag1) gene 29
Dystroglycan's core protein revival: more on domain organization and function 29
A synthetic peptide corresponding to the 550-585 region of alpha-dystroglycan binds beta-dystroglycan as revealed by NMR spectroscopy. 29
Assessing the role of the ±/²-dystroglycan interface for the processing and maturation of the dystroglycan precursor 29
Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex 28
Dystroglycan: a possible mediator for reducing congenital muscular dystrophy? 28
Structural characterization by NMR of the natively unfolded extracellular domain of beta-dystroglycan: toward the identification of the binding epitope for alpha-dystroglycan 28
Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution 28
The molecular basis of alpha-dystroglycan hypoglycosylation: a crystallographic and SAXS study 28
The human keratoepithelin FAS1-4 domain as a model for the study of protein misfolding and amyloidogenesis: recombinant expression and preliminary characterisation 27
Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression 27
alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy 27
Quantification, 2DE analysis and identification of enriched glycosylated proteins from mouse muscles: Difficulties and alternatives 27
Corneal deposit of ciprofloxacin after Laser Sub-Epithelial Keratomileusis (LASEK) procedure. 27
Structural and functional analysis of the N-terminal extracellular region of beta-dystroglycan. 27
Cib2 binds integrin alpha 7B beta 1D and is reduced in laminin alpha 2 chain-deficient muscular dystrophy 27
The dystroglycan complex: From biology to cancer 26
FRAP analysis of dystroglycan, a membrane receptor involved in congenital muscular dystrophies 26
Insertion of a myc-tag within alpha-dystroglycan domains improves its biochemical and microscopic detection 26
Role of gelatinases in pathological and physiological processes involving the dystrophin-glycoprotein complex 26
Looking into the mechanism of a hetero-oligomeric class II chaperonin 26
Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex. 26
Immunodetection of partially glycosylated isoforms of alpha-dystroglycan by a new monoclonal antibody against its beta-dystroglycan-binding epitope 26
Insertion of 16 Amino Acids in the BAR Domain of the Oligophrenin 1 Protein Causes Mental Retardation and Cerebellar Hypoplasia in an Italian Family 26
Insights into the structure of the N-terminal region of alpha-dystroglycan: a concerted crystallographic and SAXS study 25
Totale 5.316
Categoria #
all - tutte 17.477
article - articoli 10.601
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.078


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20248 0 0 0 0 0 0 0 0 1 0 5 2
2024/20252.065 1 9 155 71 480 253 10 72 44 69 499 402
2025/20264.235 127 306 369 469 464 166 463 168 1.471 115 117 0
Totale 6.308